Holen Sie sich die Stockscreener-App
0.4491
5.52%
0.0235
Handel nachbörslich:
.45
0.0009
+0.20%
Schlusskurs vom Vortag:
$0.4256
Offen:
$0.43
24-Stunden-Volumen:
600.88K
Relative Volume:
0.30
Marktkapitalisierung:
$63.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-119.76M
KGV:
-0.3327
EPS:
-1.35
Netto-Cashflow:
$-55.17M
1W Leistung:
-4.45%
1M Leistung:
+8.50%
6M Leistung:
-22.07%
1J Leistung:
-92.77%
1-Tages-Spanne:
$0.43
$0.4587
1-Wochen-Bereich:
$0.422
$0.4833
52-Wochen-Spanne:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Firmenname
Applied Therapeutics Inc
Sektor
Branche
Telefon
212-220-9226
Adresse
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Vergleichen Sie APLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4491 | 62.92M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
638.90 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Eingeleitet | William Blair | Outperform |
| 2024-03-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-22 | Eingeleitet | Leerink Partners | Outperform |
| 2022-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Herabstufung | Goldman | Neutral → Sell |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2020-10-08 | Eingeleitet | Truist | Buy |
| 2020-04-22 | Eingeleitet | Goldman | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-06-10 | Eingeleitet | Citigroup | Buy |
| 2019-06-10 | Eingeleitet | Cowen | Outperform |
| 2019-06-10 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Applied Therapeutics Inc Aktie (APLT) Neueste Nachrichten
Applied Therapeutics Inc.’s Beta Climbs After Market VolatilityBuy Alerts With Low Risk Confirmation Noted - metal.it
Applied Therapeutics (APLT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
What institutional investors are buying Applied Therapeutics Inc. stockUnlock powerful investment tools for free - Jammu Links News
What are the latest earnings results for Applied Therapeutics Inc.Free Stock Selection - Jammu Links News
What are analysts’ price targets for Applied Therapeutics Inc. in the next 12 monthsOutstanding growth strategies - Jammu Links News
What catalysts could drive Applied Therapeutics Inc. stock higher in 2025Achieve breakthrough financial results - Jammu Links News
How does Applied Therapeutics Inc. generate profit in a changing economyInvest confidently with professional market insights - Jammu Links News
What are Applied Therapeutics Inc. company’s key revenue driversHigh-octane investment opportunities await - Jammu Links News
How volatile is Applied Therapeutics Inc. stock compared to the marketGet high-impact stock recommendations now - Jammu Links News
Published on: 2025-08-03 15:52:53 - Jammu Links News
Applied Therapeutics Inc. Stock Analysis and ForecastBuild a diversified portfolio for risk management - Jammu Links News
What drives Applied Therapeutics Inc. stock priceMaximize your portfolio’s growth potential - Jammu Links News
What analysts say about Applied Therapeutics Inc. stockBuild a portfolio that delivers consistent profits - Jammu Links News
What makes Applied Therapeutics Inc. stock price move sharplyEarnings Report Entry Points For Fast Growth - Jammu Links News
Applied Therapeutics Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Brokerages Set Applied Therapeutics Inc. (NASDAQ:APLT) PT at $6.10 - MarketBeat
What is the dividend policy of Applied Therapeutics Inc. stockValue Investing Picks For Every Investor - Jammu Links News
Is Applied Therapeutics Inc. still worth holding after the dipBuy Alerts With Low Risk Confirmation Noted - metal.it
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit – APLT - ACCESS Newswire
Wall Street Zen Upgrades Applied Therapeutics (NASDAQ:APLT) to Sell - MarketBeat
Published on: 2025-07-29 13:58:52 - metal.it
Why Applied Therapeutics Inc. stock attracts strong analyst attentionLow Capital High Return Stock Plans Reviewed - metal.it
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
How does Applied Therapeutics Inc. compare to its industry peersRemarkable growth - jammulinksnews.com
Applied Therapeutics (NASDAQ:APLT) Stock Price Down 5%What's Next? - MarketBeat
What is Applied Therapeutics Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com
Published on: 2025-07-28 02:44:29 - Jammu Links News
Is Applied Therapeutics Inc. a good long term investmentFree Consultation - PrintWeekIndia
Should I buy Applied Therapeutics Inc. stock before earningsFree Investment Risk Control - Jammu Links News
How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser
Finanzdaten der Applied Therapeutics Inc-Aktie (APLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Applied Therapeutics Inc-Aktie (APLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
| Funtleyder Leslie D. | Chief Financial Officer |
Aug 22 '24 |
Sale |
5.83 |
13,530 |
78,880 |
277,911 |
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
3.70%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):